A 3-armed multicenter randomized controlled trial: Placental Transfusion in Very Preterm Infants (PT-VPI)

Contemp Clin Trials. 2021 Apr;103:106337. doi: 10.1016/j.cct.2021.106337. Epub 2021 Mar 2.

Abstract

Preterm infants constitute an important proportion of neonatal deaths and various complications, and very preterm infants (VPI) are more likely to develop severe complications, such as intraventricular hemorrhage (IVH), anemia, and sepsis. It has been confirmed that placental transfusion can supplement blood volume in infants and reduce preterm-associated complications, which is further conducive to the development of the nervous system and a better long-term prognosis. Based on these advantages, placental transfusion has been widely used in VPI. There are three main types of placental transfusion: delayed cord clamping (DCC), intact umbilical cord milking (I-UCM), and cut umbilical cord milking (C-UCM). However, the optimal method for PT-VPI remains controversial, and it is urgent to identify the best method of placental transfusion. We plan to fully evaluate the safety and effectiveness of these three placental transfusion methods in VPI in a 3-arm multicenter randomized controlled trial: Placental Transfusion in Very Preterm Infants (PT-VPI). Trial registration: chictr.org.cn, number ChiCTR2000030953.

Keywords: Cut umbilical cord milking; Delayed cord clamping; Intact umbilical cord milking; Placental transfusion; Umbilical cord milking; Very preterm infants.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Transfusion
  • Constriction
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Placenta*
  • Pregnancy
  • Umbilical Cord

Associated data

  • ChiCTR/ChiCTR2000030953